Results 101 to 110 of about 22,506 (225)

Precision-guided, personalized intrapleural fibrinolytic therapy for empyema and complicated parapneumonic pleural effusions: The case for the fibrinolytic potential

, 2017
Complicated pleural effusions and empyema with loculation and failed drainage are common clinical problems. In adults, intrapleural fibrinolytic therapy (IPFT) is commonly used with variable results, and therapy remains empiric.
Galina Florova, Azghani, A, Ali Azghani, Sreerama Shetty, Rahman, NM, Tucker, T, Richard Idell, Andrey Komissarov, Florova, G, Komissarov, A, Rahman, Najib, Najib M. Rahman, Steven Idell, Torry Tucker, Idell, R, Idell, S, Kathy Koenig, Shetty, S, Koenig, K   +18 more
core   +1 more source

Fibrinolytic and defibrinogenation therapy

, 1983
Plasma fibrinogen is one of the main determinants of blood viscosity and is known to play an important role in the pathogenesis of venous and arterial thromboembolism.
P.M. Mannucci, D. Mari
core  

Quantitative evaluation of fibrinolytic enzymes in a simulated human system

, 1964
A simple in vitro system for the assay of fibrinolytic enzymes intended for therapeutic use has been described. The system employs small quantities of human plasma from outdated bank blood as perfusing medium and purified human fibrin clots labeled with
Clara M. Ambrus, Nathan Back, Howard Lassman, Albert E. Munson, Julian L. Ambrus, Eugene Lippschutz   +5 more
core   +1 more source

Oral fibrinolytic agents. [PDF]

BMJ, 1968
G R, Fearnley, R, Chakrabarti
openaire   +2 more sources

Inherited disorders of the fibrinolytic pathway

, 2019
© 2019 Deficiencies or excessive activation of the fibrinolytic system can result in severe, lifelong bleeding disorders. The most severe clinical phenotype is caused by α2−Antiplasmin (α2−AP) deficiency which results in excess fibrinolysis due to the ...
Jain, S., Acharya, S. S.
core   +1 more source

Purification and Characterization of a Novel Fibrinolytic Enzyme from Marine Bacterium Bacillus sp. S-3685 Isolated from the South China Sea

Marine Drugs
A novel fibrinolytic enzyme, BSFE1, was isolated from the marine bacterium Bacillus sp. S-3685 (GenBank No.: KJ023685) found in the South China Sea.
Zibin Ma, Jeevithan Elango, Jianhua Hao, Wenhui Wu   +3 more
doaj   +1 more source

Fibrinolytic activity of Amirkabiria odoratissima Mozaffarian

Journal of Medicinal Plants, 2005
Background: fibrinolytic agents like streptokinase (SK) and urokinase (UK) are urgent treatment of thromboembolism. Besides thrombolysis, these medications have side effect like: generalized lytic state, serum fibrinogen decrease, effect on body ...
S Asgary, Gh Naderi, A Jafariyan, N Askary, AR Behagh   +4 more
doaj  

Studies on Fibrinolytic agent(s) from endophytic fungi

, 2017
The present study was oriented towards exploration of potential endophytic fungi isolated from conserved rain forests of India for their fibrinolytic activity.
Meshram, Vineet
core  

The efficacy and safety of anti-fibrinolytic agents in blood management following peri-acetabular osteotomy: A meta-analysis. [PDF]

Medicine (Baltimore), 2018
Wang M, Tan H, Wu Z, Liang Y.
europepmc   +1 more source

Production of Fibrinolytic Enzyme from Bacillus amyloliquefaciens by Fermentation of Chickpeas, with the Evaluation of the Anticoagulant and Antioxidant Properties of Chickpeas

, 2011
To develop safe and cheap thrombolytic agents, a fibrinolytic enzyme productive strain of LSSE-62 was isolated from Chinese soybean paste. This strain was identified as Bacillus amyloliquefaciens by 16S rDNA sequence analysis.
Luo, MF, Xuetuan Wei, Luo, Mingfang, Lin Xu, Xu, Lin, Liu, Huizhou, Yewei Zhang, Kong, Peng, Lin, Xing, Wei, Xuetuan, Mingfang Luo, Zhang, Yewei, Xing Lin, Huizhou Liu, Peng Kong   +14 more
core   +1 more source